• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
It's not an easy fix: Adherence to adjuvant endocrine therapy after breast cancer.这并非易事:乳腺癌辅助内分泌治疗的依从性
Can Oncol Nurs J. 2021 May 1;31(2):221-227. eCollection 2021 Spring.
2
Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.患者报告的与乳腺癌辅助内分泌治疗依从性相关的因素:综合评价。
Breast Cancer Res Treat. 2018 Feb;167(3):615-633. doi: 10.1007/s10549-017-4561-5. Epub 2017 Nov 6.
3
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.了解乳腺癌幸存者辅助内分泌治疗的持续情况。
BMC Cancer. 2018 Jul 11;18(1):732. doi: 10.1186/s12885-018-4644-7.
4
Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study.解析乳腺癌幸存者启动、维持或终止辅助内分泌治疗的决策:一项混合方法研究。
Oncol Nurs Forum. 2017 May 1;44(3):E101-E110. doi: 10.1188/17.ONF.E101-E110.
5
Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer.医疗服务提供者对乳腺癌辅助内分泌治疗依从性的看法。
Curr Oncol. 2021 Apr 9;28(2):1472-1482. doi: 10.3390/curroncol28020139.
6
Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management.影响乳腺癌治疗后女性接受辅助内分泌治疗依从性的因素:利用真实世界数据为从急性疾病管理向慢性疾病管理的转变提供信息。
Breast Cancer Res Treat. 2020 Aug;183(1):189-199. doi: 10.1007/s10549-020-05748-6. Epub 2020 Jun 26.
7
The experiences of adjuvant endocrine therapy for women breast cancer survivors: A literature review.辅助内分泌治疗乳腺癌幸存者的体验:文献回顾。
Medicine (Baltimore). 2023 Dec 22;102(51):e36704. doi: 10.1097/MD.0000000000036704.
8
Development of a community pharmacy-based intervention to enhance adherence to adjuvant endocrine therapy among breast cancer survivors guided by the Intervention Mapping approach.基于社区药房的干预措施的开发,以提高乳腺癌幸存者对辅助内分泌治疗的依从性,该干预措施由干预映射方法指导。
Res Social Adm Pharm. 2020 Dec;16(12):1724-1736. doi: 10.1016/j.sapharm.2020.02.004. Epub 2020 Feb 12.
9
Concurrent factors associated with adherence to adjuvant endocrine therapy among women with non-metastatic breast cancer.非转移性乳腺癌女性辅助内分泌治疗依从性的相关并发因素。
J Cancer Surviv. 2024 Feb 24. doi: 10.1007/s11764-024-01556-9.
10
Systematic adaptation of the adherence improving self-management strategy to support breast cancer survivors' adherence to adjuvant endocrine therapy: An intervention mapping approach.系统改编提高依从性的自我管理策略以支持乳腺癌幸存者对辅助内分泌治疗的依从性:一种干预映射方法。
Eur J Cancer Care (Engl). 2022 Nov;31(6):e13721. doi: 10.1111/ecc.13721. Epub 2022 Oct 20.

本文引用的文献

1
Projected estimates of cancer in Canada in 2020.2020 年加拿大癌症预估。
CMAJ. 2020 Mar 2;192(9):E199-E205. doi: 10.1503/cmaj.191292.
2
Interventions to Improve Medication Adherence: A Review.干预措施以提高用药依从性:综述。
JAMA. 2018 Dec 18;320(23):2461-2473. doi: 10.1001/jama.2018.19271.
3
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.激素受体阳性乳腺癌妇女的辅助内分泌治疗:ASCO 临床实践指南更新焦点。
J Clin Oncol. 2019 Feb 10;37(5):423-438. doi: 10.1200/JCO.18.01160. Epub 2018 Nov 19.
4
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.了解乳腺癌幸存者辅助内分泌治疗的持续情况。
BMC Cancer. 2018 Jul 11;18(1):732. doi: 10.1186/s12885-018-4644-7.
5
Women's Beliefs on Early Adherence to Adjuvant Endocrine Therapy for Breast Cancer: A Theory-Based Qualitative Study to Guide the Development of Community Pharmacist Interventions.女性对乳腺癌辅助内分泌治疗早期依从性的信念:一项基于理论的定性研究,以指导社区药剂师干预措施的制定。
Pharmacy (Basel). 2018 Jun 9;6(2):53. doi: 10.3390/pharmacy6020053.
6
Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?改善乳腺癌幸存者内分泌治疗依从性的干预措施:有哪些证据?
J Cancer Surviv. 2018 Jun;12(3):348-356. doi: 10.1007/s11764-017-0674-4. Epub 2018 Feb 2.
7
Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.患者报告的与乳腺癌辅助内分泌治疗依从性相关的因素:综合评价。
Breast Cancer Res Treat. 2018 Feb;167(3):615-633. doi: 10.1007/s10549-017-4561-5. Epub 2017 Nov 6.
8
Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review.乳腺癌女性辅助激素治疗依从性和持续性的障碍与促进因素:一项系统综述
Patient Prefer Adherence. 2017 Feb 23;11:305-322. doi: 10.2147/PPA.S126651. eCollection 2017.
9
"Winging It": How Older Breast Cancer Survivors Persist With Aromatase Inhibitor Treatment.“随机应变”:老年乳腺癌幸存者如何坚持接受芳香化酶抑制剂治疗
J Oncol Pract. 2016 Dec;12(12):e991-e1000. doi: 10.1200/JOP.2016.011767. Epub 2016 Sep 30.
10
Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis.探索医生就辅助内分泌治疗与正在接受治疗的乳腺癌患者沟通的作用:一项定性分析。
Support Care Cancer. 2017 Jan;25(1):75-83. doi: 10.1007/s00520-016-3389-6. Epub 2016 Aug 24.

这并非易事:乳腺癌辅助内分泌治疗的依从性

It's not an easy fix: Adherence to adjuvant endocrine therapy after breast cancer.

作者信息

Lambert Leah K, Balneaves Lynda G, Howard A Fuchsia

机构信息

School of Nursing, University of British Columbia, T201-2211 Wesbrook Mall, Vancouver, BC V6T 2B5; British Columbia Cancer, 600 W 10th Ave, Vancouver, BC V5Z 4E6.

College of Nursing, Rady Faculty of Health Sciences, University of Manitoba, 89 Curry Place, Helen Glass Centre for Nursing, Winnipeg, MB R3T 2N2.

出版信息

Can Oncol Nurs J. 2021 May 1;31(2):221-227. eCollection 2021 Spring.

PMID:34036161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8128422/
Abstract

Adjuvant endocrine therapy (AET) is a highly efficacious treatment that significantly reduces breast cancer recurrence and mortality for women with hormone-receptor positive breast cancer. Yet, many women do not adhere to prescribed AET. The overarching aim of this research was to gain a better understanding of why a significant number of women diagnosed with breast cancer have suboptimal adherence to AET. A mixed-methods approach was used to explore the personal, social, and structural factors influencing breast cancer survivors' AET adherence, including: (1) an integrative review of patient-reported factors associated with AET adherence; and (2) interviews with breast cancer survivors prescribed AET. In this paper, we summarize and discuss the key contributions of both phases of this research, implication for clinical practice, and how we might leverage the expertise of nurses in practicing to full scope to address the complex needs of breast cancer survivors prescribed AET.

摘要

辅助内分泌治疗(AET)是一种高效的治疗方法,可显著降低激素受体阳性乳腺癌女性的乳腺癌复发率和死亡率。然而,许多女性并未坚持规定的AET治疗。本研究的总体目标是更好地理解为什么大量被诊断为乳腺癌的女性对AET的依从性欠佳。采用了混合研究方法来探究影响乳腺癌幸存者AET依从性的个人、社会和结构因素,包括:(1)对与AET依从性相关的患者报告因素进行综合综述;以及(2)对接受AET治疗的乳腺癌幸存者进行访谈。在本文中,我们总结并讨论了本研究两个阶段的关键贡献、对临床实践的启示,以及我们如何利用护士的专业知识,充分发挥其作用,以满足接受AET治疗的乳腺癌幸存者的复杂需求。